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Background Cardiovascular disease (CVD) is the leading cause of premature death and 
disability in Europe. Effective cardiac rehabilitation (CR) can improve mortality and 
morbidity rates, yet uptake of community-based CR is low (Department of Health and 
Children, 2010). PATHway (Physical Activity Towards Health) is a technology enabled 
behaviour change intervention designed to enable patients to self-manage their health. 
Aims From a patient’s perspective, this study aims to determine the key personal, social 
and physical factors that inhibit or promote a patient’s capacity to engage with a 
technology enabled CR programme. From a healthcare professional’s perspective, this 
study aims to explore a) opinions and preferences for the most appropriate content and 
most viable approach for delivery of the PATHway intervention, b) strategies for 
recruitment and retention of study participants, c) treatment adherence, and d) strategies 
to overcome barriers to the acceptability of the intervention in the proposed study. 
Methods 40 individual patient interviews and 21 individual healthcare professional 
interviews were conducted across two sites (Dublin, Ireland and Leuven, Belgium). The 
COM-B model of behaviour change (Michie et al. 2011) was used to develop interview 
scripts and provided a framework to analyse all interviews assessing 1) capability, 2) 
opportunity and 3) motivation to engage with PATHway. Thematic analysis was also 
used (Braun & Clarke, 2006). Results Capability: Some patients felt unsure of physical 
capability to engage with PATHway, while psychological capability could be 
summarized in terms of patients’ psychological readiness but also technological readiness 
to engage with the intervention. Opportunity: Participants felt the main obstacles were 
around time, space and equipment. Patients suggested a family-wide intervention may 
facilitate greater opportunity for engagement. Motivation: Patients identified several 
factors that influenced motivation including goal setting, social interaction, perceptions, 
monitoring, personalization and present/future health and well-being. Health professional 
themes which they deemed would influence engagement with a technology-enabled 
intervention, including 1) capitalizing on the ‘age of measurement’, 2) harnessing Phase 2 
connections, 3) practical ‘barriers to PATHway implementation’, 4) adopting a ‘patient-
centred approach’ and 5) implementing key ‘technology recommendations’. Discussion 
and Conclusion This formative work has outlined key patient and stakeholder concerns 
regarding engagement with a technology enabled behavior change intervention in CR. 
Factors that inhibit and promote engagement have been explored using the COM-B 
framework. Motivational factors related to social interaction were deemed one of the 
integral aspects for engagement and adherence to PATHway. In terms of capability 
factors, technology ease- of-use was highlighted among patient and stakeholders as 
important for uptake and continued use. This project has received funding from the 
European Union’s Horizon 2020 Framework Programme for Research and Innovation 
Action under Grant Agreement no. 643491. PATHway: Technology enabled behavioural 
change as a pathway towards better self-management of CVD (www.pathway2health.eu) 
